Hydroxychloroquine is a lysosomotropic agent used in malaria prophylaxis and treatment. It is researched in oncology for its in vitro pro-apoptotic effects on renal cancer cells and as a TLR7/9 inhibitor. Studies also explore its immunomodulatory potential in autoimmune diseases and viral infections.